Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1820190 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $6.82Day −2.99%Mkt cap $58M1Y −29.4%Off 52W high −68.0%Vol (1Y) 117.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 925 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.5% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−2.30% |
| Top-10 13F concentration96.8% |
| Next report (est.)2026-08-21 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$33.9M |
| Earnings (TTM)-$393.6M |
| Net margin−1236.4% |
| Sales growth 3Y−7.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−10.2% |
| 1Y−29.4% |
| 3Y−94.2% |
| Since incept. (ann.)−60.0% |
Price return through 2026-07-28 · series begins 2022-11-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)117.1% |
| Ann. volatility (3Y)120.6% |
| Sharpe (1Y)0.27 |
| Sharpe (3Y)−0.19 |
| Max drawdown (1Y)−80.3% |
| Max drawdown (3Y)−98.2% |
| Beta (3Y vs SPY)3.56 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 297,706 | $2M | 3.51% | −37.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 264,050 | $2M | 3.11% | new |
| BlackRock, Inc. | 102,796 | $684,622 | 1.21% | +4.5% |
| VANGUARD FIDUCIARY TRUST CO | 39,658 | $264,122 | 0.47% | new |
| RENAISSANCE TECHNOLOGIES LLC | 36,864 | $245,514 | 0.43% | −4.2% |
| STATE STREET CORP | 35,376 | $235,604 | 0.42% | +3.0% |
| XTX Topco Ltd | 22,606 | $150,556 | 0.27% | +10.6% |
| Ashton Thomas Private Wealth, LLC | 17,989 | $119,807 | 0.21% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-20 | — | — | $8.6M | +72.1% |
| 2025-12-31 | 2026-04-10 | — | — | $4.8M | −67.8% |
| 2025-09-30 | 2025-11-14 | — | — | $10.6M | −26.8% |
| 2025-06-30 | 2025-08-13 | — | — | $9.9M | −39.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-21 is ESTIMATED from filing cadence (median gap 93d) — not company-confirmed.
